CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $176,000 | +20.5% | 87,340 | +62.3% | 0.00% | – |
| Q4 2021 | $146,000 | -57.7% | 53,830 | -30.5% | 0.00% | – |
| Q3 2021 | $345,000 | +12.4% | 77,423 | +46.1% | 0.00% | – |
| Q2 2021 | $307,000 | +17.6% | 52,985 | +111.9% | 0.00% | – |
| Q4 2019 | $261,000 | -87.0% | 25,000 | -95.1% | 0.00% | -100.0% |
| Q3 2019 | $2,002,000 | +438.2% | 509,320 | +1937.3% | 0.00% | – |
| Q2 2019 | $372,000 | -77.0% | 25,000 | -61.5% | 0.00% | -100.0% |
| Q1 2019 | $1,614,000 | +27.9% | 65,000 | -7.5% | 0.00% | 0.0% |
| Q4 2018 | $1,262,000 | -82.5% | 70,291 | -71.4% | 0.00% | -77.8% |
| Q3 2018 | $7,220,000 | +82.8% | 245,838 | +323.4% | 0.01% | +50.0% |
| Q4 2017 | $3,949,000 | +8.5% | 58,067 | +31.5% | 0.01% | 0.0% |
| Q3 2017 | $3,639,000 | +41.9% | 44,162 | +61.2% | 0.01% | +20.0% |
| Q2 2017 | $2,565,000 | +256400.0% | 27,393 | +124413.6% | 0.01% | – |
| Q1 2017 | $1,000 | -99.9% | 22 | -100.0% | 0.00% | -100.0% |
| Q4 2016 | $1,994,000 | +6.7% | 44,900 | -13.4% | 0.00% | 0.0% |
| Q3 2016 | $1,869,000 | +2570.0% | 51,830 | +2491.5% | 0.00% | – |
| Q4 2015 | $70,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |